You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GSK-3β

Showing 1 - 25 of 8,770
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Adenocarcinoma Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jun 7, 2022

Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fairway, Kansas
    Kansas University Cancer center
Nov 2, 2022

Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

Withdrawn
  • Salivary Gland Carcinoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 5, 2022

Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer Trial in Boston (9-ING-41, Carboplatin)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 15, 2021

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

Withdrawn
  • Soft Tissue Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Nov 30, 2021

Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

Withdrawn
  • Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Jul 26, 2021

Non-alcoholic Fatty Liver Disease Trial (GSK4532990, Placebo)

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease
  • (no location specified)
Dec 14, 2022

Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)

Active, not recruiting
  • Influenza, Human
  • GSK4382276A Dose level 1
  • +4 more
  • Edegem, Belgium
  • +6 more
Jan 9, 2023

Herpes Zoster Trial in India (HZ/su, Placebo)

Active, not recruiting
  • Herpes Zoster
  • HZ/su
  • Placebo
  • Visakhapatnam, Andhra Pradesh, India
  • +8 more
Jan 6, 2023

Aging, Metabolism Disorder, Ketonemia Trial in Aarhus (D-ß-hydroxybutyrate/D 1,3 butanediol monoester)

Recruiting
  • Aging
  • +3 more
  • D-β-hydroxybutyrate/D 1,3 butanediol monoester
  • Aarhus, Aarhus N, Denmark
    Steno Diabetes Center Aarhus
Feb 8, 2023

Respiratory Syncytial Viruses Trial in Canada, United Kingdom, United States (RSVPreF3 OA investigational vaccine, HZ/su

Not yet recruiting
  • Respiratory Syncytial Viruses
  • RSVPreF3 OA investigational vaccine
  • HZ/su vaccine
  • Daphne, Alabama
  • +23 more
Jul 21, 2023

Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT, Placebo)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSV MAT
  • Placebo
  • Birmingham, Alabama
  • +162 more
Dec 22, 2022

Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • San Diego, California
  • +99 more
Oct 6, 2023

Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Victoria, British Columbia, Canada
  • +10 more
Jan 23, 2023

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, Placebo)

Recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • Placebo
  • Daphne, Alabama
  • +56 more
Jan 20, 2023

NASH Trial in Nottingham (Aramchol)

Completed
  • NASH
  • Nottingham, United Kingdom
    Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nott
May 23, 2023

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Not yet recruiting
  • Warts
  • Detection of expression of SOCS3 gene
  • +2 more
  • (no location specified)
Mar 12, 2023

Systemic Lupus Erythematosus Trial in Worldwide (BENLYSTA, SLE treatment)

Active, not recruiting
  • Systemic Lupus Erythematosus
  • BENLYSTA
  • SLE treatment
  • Birmingham, Alabama
  • +177 more
Jan 23, 2023

Osteoarthritis, Knee Trial in Dhaka (Astaxanthin Oral Capsule, Placebo)

Recruiting
  • Osteoarthritis, Knee
  • Astaxanthin Oral Capsule
  • Placebo
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Jun 29, 2022

Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA Investigational Vaccine)

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA Investigational Vaccine
  • Phoenix, Arizona
  • +52 more
Jun 16, 2023

Aging Trial in Bath (Ketone drink, Placebo)

Recruiting
  • Aging
  • Ketone drink
  • Placebo
  • Bath, Somerset, United Kingdom
    University of Bath
Sep 28, 2023

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)

Active, not recruiting
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Birmingham, Alabama
  • +49 more
Dec 26, 2022

Respiratory Syncytial Virus Infections Trial in Fukuoka (RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B, Placebo)

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B
  • Placebo
  • Fukuoka, Japan
    GSK Investigational Site
Dec 7, 2021

Respiratory Syncytial Virus Infections Trial in Canada, Sweden, United States (RSVPreF3 OA investigational vaccine)

Completed
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • Waterbury, Connecticut
  • +19 more
Aug 5, 2022